Health

FDA Approves New Blood Cancer Drug

Updated 2026-08-30 18:40 UTC 1 source Positive

The FDA has approved Mimrylo, a new treatment for polycythemia vera developed by Takeda and Protagonist. This marks an advancement in the management of this rare blood cancer.

Coverage timeline — 1 article

STAT News

STAT+: FDA approves Protagonist and Takeda’s drug for rare blood cancer

Mimrylo, from Takeda and Protagonist, is a new kind of treatment for the blood cancer polycythemia vera.

2026-08-30 18:30 UTC